Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators
- 1 July 2017
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 128, 28-41
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Inhaled corticosteroids in COPD and the risk of serious pneumoniaThorax, 2013
- Combination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseRespiratory Research, 2013
- COPD symptoms in the morning: impact, evaluation and managementRespiratory Research, 2013
- Efficacy and safety of NVA237versusplacebo and tiotropium in patients with COPD: the GLOW2 studyEuropean Respiratory Journal, 2012
- Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trialsBMJ, 2011
- Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costsRespiratory Medicine, 2010
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010
- Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPDPulmonary Pharmacology & Therapeutics, 2010
- Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialThe Lancet, 2009
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008